Testing effectiveness (Phase 2)Study completedNCT00089401
What this trial is testing
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver
Who this might be right for
Colorectal CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 8